Report Library
All Reports
Q3 2016 Outlook Report
July 06, 2016
In this report, we cover catalysts from 24 drugs, devices and diagnostics expected to occur in Q3 2016. We have also included a list of
Large Impact catalysts in the drug and device/diagnostic areas through Q3 2016. In addition, each drug’s
likelihood of
Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are
provided.
Our Q2 2016 Outlook Report highlighted several high- impact catalysts. The results of these catalysts can be found on Page 5 of this report. Biomedtracker Likelihood of Approval (LOA) opinions successfully predicted 63% of catalyst outcomes that occurred in Q2 2016.
For the full report, please download the PDF version at the top of this page. Additionally, the catalyst calendars are provided in Excel by downloading the supplemental material above.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the BioMedTracker Research Standards.
Our Q2 2016 Outlook Report highlighted several high- impact catalysts. The results of these catalysts can be found on Page 5 of this report. Biomedtracker Likelihood of Approval (LOA) opinions successfully predicted 63% of catalyst outcomes that occurred in Q2 2016.
For the full report, please download the PDF version at the top of this page. Additionally, the catalyst calendars are provided in Excel by downloading the supplemental material above.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the BioMedTracker Research Standards.
| Indications Covered: |
Amyotrophic Lateral Sclerosis (ALS)
Anti-Parasitic and Anti-Protozoal Cardiac Valve Surgery Chronic Heart Failure - Reduced Ejection Fraction (Chronic HFrEF) Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL Chronic Pain Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) Crohn's Disease Drug Toxicity Dry Eye (Ophthalmology) Dyslipidemia / Hypercholesterolemia Glaucoma / Ocular Hypertension (Ophthalmology) Hemostasis Hyperparathyroidism (Secondary) Melanoma Non-Alcoholic Steatohepatitis (NASH) Opioid Induced Constipation (OIC) Psoriasis Rheumatoid Arthritis (RA) Sarcoma - Unspecified |
Additional Resources: